Absorbable Surgical Sutures Market

Absorbable Surgical Sutures Market Size

The global absorbable surgical sutures market was estimated at USD 3 billion in 2024. The market is expected to grow from USD 3.2 billion in 2025 to USD 5.2 billion in 2034, growing at a CAGR of 5.6%. The global market is expanding steadily, driven by the rising prevalence of chronic diseases, an increase in surgical procedures worldwide, advancements in suture materials, and a growing number of gynecological surgeries.

Absorbable surgical sutures are a type of medical threads which are designed to close wounds or surgical incisions by naturally degrading in the body over time, which eliminates the need for removal. These sutures play an important role in clinical settings and are widely used across hospitals, surgical centres, and outpatient facilities. Major players in the absorbable surgical sutures industry includes Johnson & Johnson, Medtronic, B. Braun, Integra Lifesciences, and Lotus Surgicals. The market primarily focuses on products such as monofilament and multifilament sutures, along with specialized variants such as coated sutures, antibacterial sutures, and barbed sutures, which are further designed to enhance wound healing, reduce infection risk, and also improve surgical efficiency for healthcare professionals.

The market increased from USD 2.6 billion in 2021 to USD 2.9 billion in 2023, registering a CAGR of 5.6% during this period. This growth was driven by the rising demand for minimally invasive surgeries, growing awareness of post-operative care, and expanding global healthcare infrastructure. Additionally, continuous innovations in absorbable suture technologies, such as antibacterial coatings, barbed sutures, and advanced polymer materials, have significantly improved wound healing, reduced infection risks, and eliminated the need for suture removal. The growing focus on efficient surgical procedures and faster patient recovery in hospitals and surgical centres has further contributed to the market's growth.

The increasing prevalence of chronic diseases further accelerates the growth of the market. For instance, in 2021, as per the data from the World Health Organization (WHO), non-communicable disease was responsible for 43 million deaths worldwide. Among the million, cardiovascular disease was responsible for at least 19 million deaths, followed by cancer with 10 million. The growing number of patients undergoing surgical interventions for these chronic conditions creates the demand for effective wound care, which is estimated to reach USD 44.2 billion by 2034 solutions, such as absorbable surgical sutures. These sutures help faster healing, reduce the need for follow-up procedures, and minimize the risk of infection. Thus, the increasing demand for advanced surgical tools and post-operative care is expected to significantly accelerate the growth of the market.

In addition, the absorbable surgical sutures market is experiencing strong growth due to ongoing advancements in suture materials. These innovations are enhancing healing outcomes, reducing infection risks, and improving overall patient comfort. Advanced solutions, such as antibacterial coatings and barbed sutures, are transforming wound closure into multifunctional tools. For example, Johnson & Johnson offers a comprehensive range of absorbable sutures, including Vicryl, Monocryl, and PDS II. These products feature advanced attributes such as antibacterial coatings and barbed designs, which help to promote faster healing and reduce post-operative complications.

Absorbable surgical sutures are sterile medical threads used to close wounds or surgical incisions. They are designed to naturally break down and be absorbed by the body over time, eliminating the need for removal. Typically made from materials such as polyglycolic acid (PGA), polylactic acid (PLA), or polydioxanone (PDO), these sutures provide critical wound support during the healing process before being safely degraded by the body.

Absorbable Surgical Sutures Market Trends

The rise in the surgical procedure across the world has emerged as a key catalyst driving the growth of the market. As medical interventions have become increasingly advanced and accessible, this has led to the demand for the effective absorbable surgical suture’s solutions, experiencing parallel growth.

• As per estimates, the U.S. alone performs more than 42,97,000 elective procedures, including both surgical and non-surgical interventions, every month. Among these procedures, 46.6% are of surgical nature, requiring the utilization of operation rooms.
  
• Similarly, according to the International Society of Aesthetic Plastic Surgery (ISAPS) conducted a global survey in 2022, in that survey it is estimated that the U.S. had conducted the largest number of plastic surgery procedures in the world, which is exceeding 7.4 million.
  
• Thus, the growth of elective as well as emergency procedures, including trauma cases, accidents, acute medical conditions necessitate the demand of immediate surgical interventions, thereby significantly contributing to the overall demand for advanced absorbable surgical sutures products. 
  
• Additionally, absorbable surgical sutures products play an important role not only during surgeries, but also in post-operative care, contributing to the long term care well-being of patients by promoting the optimal healing, thus accelerating the demand for the products.
  

Absorbable Surgical Sutures Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

The global market was valued at USD 2.6 billion in 2021. The market size reached USD 2.9 billion in 2023, from USD 2.8 billion in 2022.

Based on the material, the market is segmented into natural suture and synthetic suture. The synthetic suture segment accounted for 71.4% of the market in 2024 due to their high tensile strength, predictable absorption rates, and minimal tissue reaction, which makes them ideal for complex surgeries and minimally invasive interventions. The segment is expected to exceed USD 3.7 billion by 2034, growing at a CAGR of 5.7% during the forecast period. On the other hand, the natural suture segment is expected to grow with a CAGR of 5.5% from 2025 to 2034. The growth of this segment can be attributed to the rising demand for biologically derived, eco-friendly materials that offer excellent biocompatibility. These sutures are often used in procedures where gentle tissue handling, and rapid absorption are critical.

• Synthetic absorbable sutures are manufactured by using materials such as polyglycolic acid (PGA), polylactic acid (PLA), and polydioxanone (PDO), which degrade in a controlled and predictable manner. This allows surgeons to select sutures based on the specific required wound support duration, which ensures that the suture maintains strength during the critical healing phase and is absorbed once it's completed.
  
• In addition, these sutures provide reliable support during the healing process, making them suitable for both surface-level and deeper tissue closures. For example, Medtronic’s Maxon suture is well-known for its durability and is often used in procedures that require extended support.
  
• Additionally, synthetic sutures are designed to be safe and compatible with the body, reducing irritation and the risk of complications after surgery. For instance, B. Braun’s Safil suture, made from polyglycolic acid, is popular for its easy handling and low tissue reactivity, making it ideal for delicate surgeries. These qualities make synthetic sutures a top choice for healthcare professionals, driving growth in the market.
  

Based on the structure, the absorbable surgical sutures market is segmented into monofilament and multifilament. The multifilament segment accounted for the highest market share of 54.2% in 2024.

• Multifilament sutures are made of multiple braided or twisted strands, which provide excellent grip and friction. This structure allows for secure knot tying, minimizing the risk of knot slippage during and after surgery. This is especially beneficial in procedures requiring high precision and stability.
  
• For instance, Lotus Surgical’s Solus 910, a braided synthetic absorbable suture which is made from polyglactin 910, and is designed for high knot security, minimal tissue trauma, and consistent absorption, making it ideal for general and specialized surgeries.
  
• Additionally, multifilament sutures are also softer and more flexible, making them easier for surgeons to handle. This improves accuracy and reduces fatigue during longer procedures.
  
• Further, these types of sutures are used in a wide range of procedures, including gynaecological, gastrointestinal, and plastic surgeries, due to their adaptability and reliable performance. Thus, these benefits continue to drive the growth of the multifilament segment in the market.
  

Based on the application, the absorbable surgical sutures market is segmented into cardiovascular surgery, gynaecology surgery, orthopaedic surgery, ophthalmic surgery, neurological surgery, and other surgical applications. The cardiovascular surgery segment accounted for the highest market share of 24.8% in 2024.

• The extensive use of absorbable surgical sutures, particularly in cardiovascular surgery, are significantly boosting market growth.
  
• For instance, according to research published in the Thoracic Surgery Reports, over 1 million cardiac surgical procedures are performed globally each year. In high-income countries, the average cardiac surgical volume stands at 123.2 procedures per 100,000 population annually, from 27.3 in South Korea to 271.5 in the U.S. Among these, coronary artery bypass grafting (CABG) accounts for 36.7 procedures, valve surgeries for 30.8, and congenital heart surgeries for 7.9 per 100,000 population.
  
• Further, absorbable sutures play a vital role in cardiovascular applications due to their high tensile strength, minimal tissue reactivity, and predictable absorption profile, which are important in dynamic environments such as the heart and blood vessels.
  
• Moreover, innovations in suture technology, such as antibacterial coatings and barbed designs, are improving surgical precision and reducing infection risks. With cardiovascular diseases remaining a leading cause of death worldwide, the demand for advanced absorbable sutures in heart surgeries is expected to grow steadily, further driving the market growth.
  

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the absorbable surgical sutures market is segmented into hospitals, specialty clinics, ambulatory surgical centres, and other end users. The hospitals segment accounted for the highest market share of 55.2% in 2024.

• The increasing number of hospitals both in the developing and developed countries, stimulated by the growing population, increasing prevalence of chronic diseases, and advancement in the surgical sutures, all together propelling the demand for advanced absorbable surgical sutures in the newly established hospital and also in the existing hospital setting.
  
• Further, the rising number of surgical procedures, driven by aging populations, trauma cases, and chronic disease management, is fueling demand for absorbable surgical sutures in hospitals. As hospitals are the primary centres for performing a wide range of surgeries, so does the need for reliable and efficient suturing solutions continues to grow. 
  
• Additionally, the specialty clinics segment, accounting for 21% market share in 2024, is expanding quickly with the growth of dedicated focused care units and outpatient surgical centres. These clinics often perform minimally invasive and elective procedures, favoring absorbable sutures for their ease of use, reduced need for follow-up, and enhanced patient comfort.
  

Looking for region specific data?

Download Free PDF

North America dominated the global absorbable surgical sutures market with the highest market share of 40.5% in 2024. The region has advanced healthcare infrastructure, and the rate of adoption of innovative medical technologies is also high. Further, there is an increasing prevalence of chronic diseases in the U.S. and Canada, thus propelling the growth of this market.

• The U.S. market was valued at 982.5 million and USD 1 billion in 2021 and 2022, respectively. In 2024 the market size reached USD 1.1 billion from USD 1.07 billion in 2023.
  
• The growing prevalence of chronic conditions in the country is driving the need for advanced surgical interventions and effective wound care solutions. As more patients undergo procedures for diseases such as cardiovascular disorders and cancer, the demand for absorbable surgical sutures which support faster healing, reduce infection risks, and eliminate the need for suture removal is rising steadily.
  
• The U.S. is home to 6,093 hospitals as reported by the American Hospital Association, many of which are equipped with state of art operating rooms, fostering the use of conventional and advance suturing technologies.
  
• Additionally, the healthcare expenditure per capita in the U.S. surpassed USD 12,000 in 2023, which translates to significant spending on surgical tools and wound closure materials, further fueling the market expansion.
  

Europe absorbable surgical sutures market accounted for USD 668.3 million in 2024 and is anticipated to show lucrative growth over the forecast period.

• Rising prevalence of chronic diseases in the region, coupled with the increasing government initiatives to enhance healthcare infrastructure, is anticipated to spur the growth of the market.
  
• Moreover, the presence of key market players in the region reinforces Europe’s strength in the market. These companies are actively participating in innovation through the development of innovative solutions, thereby aiding market growth.
  

Germany absorbable surgical sutures market is projected to experience steady growth between 2025 and 2034.

• The country ranks among the highest in Europe for surgical procedures. Hip and knee replacement are among the most common surgeries which require high strength, durable sutures for wound closure. In 2022, Germany recorded 326.2 hip replacement procedures per 100,000 inhabitants. This indicates an aging orthopaedic patient population, that directly contributes to suture consumption.
  
• Further, the demand for advanced absorbable suture material is rising as healthcare providers increasingly aim to reduce post-operative complications such as surgical site infections (SSI) and support faster recovery.
  
• Additionally, the country’s well-established healthcare practices and research institutions, along with their emphasis on high-quality medical supplies, contribute to the widespread adoption of surgical sutures.
  

The Asia Pacific region is projected to be valued at USD 783 million in 2025 and is expected to reach USD 1.3 billion by 2034.

• The absorbable surgical sutures market in the Asia Pacific region is expanding rapidly due to the growing burden of chronic diseases and continuous advancements in sutures materials.
  
• Countries such as China, India and Japan are adopting advanced surgical technologies driven by growing demand for efficient wound closure solutions and expanding access to healthcare services.
  
• Additionally, rapid growth in the number of hospitals and specialty clinics along with government policies aimed at improving surgical capabilities is further contributing to the growth of the market in the region.
  

China absorbable surgical sutures market is poised to witness lucrative growth between 2025 – 2034.

• China’s aging population drive orthopaedic and cardiovascular suturing needs. For instance, as per the estimates from World Health Organization (WHO) in 2019, approximately 254 million people of age group 65 and above were residing in the country. This number is projected to rise significantly, with 402 million people expected to be over the age of 60 by 2040.
  
• Furthermore, the growing elderly population is at increased risk of chronic conditions such as cancer, diabetes, and cardiovascular diseases, leading to a higher volume of surgical interventions. This trend is driving the need for advanced wound care solutions, particularly absorbable surgical sutures, which support faster healing, reduce infection risks, and minimize the need for follow-up procedures.
  

Brazil is experiencing significant growth in the absorbable surgical sutures market, driven by its expanding adoption of chronic disease management.

• The rising prevalence of chronic diseases such as cardiovascular diseases, neurological disorders, and others are contributing to the growth of the market in the country.
  
• For instance, according to the Brazilian National Health Survey in 2019, there were approximately 12.95 million individuals diagnosed with cardiovascular disease (CVD) in Brazil, with 51% of the affected population being male.
  
• Additionally, the presence of dual healthcare system, Sistema Único de Saúde (SUS), that offers free access to surgical care, thus there is an increase in surgical volume in Brazil, further propelling the market growth.
  

The absorbable surgical sutures market in Saudi Arabia is expected to experience significant and promising growth from 2025 to 2034.

• The government of Saudi Arabia is significantly investing in the healthcare infrastructure, to incorporate advanced medical supplies such absorbable surgical sutures within the hospitals setting to provide utmost care to the individuals suffering from the chronic condition in the country.
  
• According to the Saudi Ministry of Health, in 2023, the government had allocated around USD 50.4 billion budget for healthcare infrastructure and social development.
  
• Such investment is anticipated to enhance the accessibility and quality of medical services, among the individuals of the country, accelerating the market growth in the country.
  

Absorbable Surgical Sutures Market Share

• The top five companies B. Braun, Medtronic, Lotus Surgicals, Integra Lifesciences, and Johnson & Johnson together account for 35.8% of the market share in the global market, which remains highly fragmented. These companies stay ahead by offering strong product portfolios, forming strategic partnerships, securing regulatory approvals, and consistently driving innovation.
  
• Johnson & Johnson continues to lead in the absorbable sutures segment. The company focuses on advanced wound closure solutions and provides a variety of synthetic absorbable sutures, including Vicryl, Monocryl, and PDS II. It is also investing in biocompatible materials, antibacterial coatings, and precision engineered needles to deliver better surgical outcomes and lower the risk of infections.
  
• Manufacturers are adopting competitive pricing strategies to expand into price sensitive markets, particularly in emerging economies. Leading players are addressing clinical needs by launching advanced absorbable sutures with predictable degradation profiles, enhanced tensile strength, and antimicrobial properties to reduce post-operative complications and improve patient recovery.
  
• Emerging trends in the absorbable surgical sutures market include the development of sterile, infection-resistant sutures and the adoption of biodegradable polymers specifically engineered for minimally invasive and robotic-assisted surgeries. These advancements are being driven by the increasing demand for precision surgical techniques, accelerated patient recovery, and the shift toward decentralized healthcare delivery models.
  

Absorbable Surgical Sutures Market Companies

Few of the prominent players operating in the absorbable surgical sutures industry include:

• Advanced Medical Solutions
• B. Braun
• Corza Medical
• CONMED
• Demetech
• Futura Surgicare
• Genesis MedTech
• Healthium Medtech
• Integra Lifesciences
• Johnson & Johnson
• Medtronic
• Lotus Surgicals
• Unisur
• Vital Sutures
• Vitrex Medical Group
  
• Johnson & Johnson

Johnson & Johnson’s absorbable sutures market lies in its precision-engineered suture and needle technologies under the Ethicon brand. The company offers a wide range of absorbable sutures, including antibacterial-coated options and knotless tissue control devices, designed to reduce infection risk and improve surgical efficiency.

• Lotus Surgicals

Lotus Surgicals differentiates itself through its commitment to precision manufacturing and a comprehensive portfolio of absorbable sutures tailored for high-acuity procedures. It offers a full range of braided and monofilament absorbable sutures, including advanced products such as Solus (PGA), Solus 910 (Polyglactin 910), and SOLUS 910 AM+ with antibacterial triclosan coating, designed for specialties such as cardiovascular, transplant, and plastic surgeries.

• Medtronic

Medtronic holds a significant share in the surgical suture market through its comprehensive surgical solutions' portfolio. Medtronic emphasizes R&D and product development offerings specialty sutures with enhances tensile strength and handling properties.

Absorbable Surgical Sutures Industry News:

• In March 2024, Advanced Medical Solutions Group plc acquired Peters Surgical, a prominent global name in specialty surgical sutures, mechanical hemostasis, and internal cyanoacrylate devices.  This acquisition significantly strengthened AMS’s product portfolio, enhanced its direct sales capabilities, and enabled geographic expansion in the surgical market.
  
• In October 2024, Corza Medical, a leading global medical technology company, launched its Onatec line of ophthalmic microsurgical sutures at the American Academy of Ophthalmology conference. This strategic introduction of specialized ophthalmic sutures expanded Corza’s product portfolio in eye surgery, enhanced surgical precision, and reinforced its position as a trusted partner in the global ophthalmic sutures market.
  
• In September 2023, Genesis MedTech, announced that its absorbable sutures with antibacterial protection have successfully obtained approval from the China's National Medical Products Administration (NMPA) for market release. This approval strengthened its market presence to offer triclosan-coated sutures and enhance its competitiveness in infection control.
  

The absorbable surgical sutures market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Material

• Natural suture
• Synthetic suture
  • Vicryl
  • Polydioxanone suture (PDS)
  • Poliglecaprone suture (Monocryl)

Market, By Structure

• Monofilament
• Multifilament

Market, By Application

• Gynaecology surgery
• Orthopaedic surgery
• Ophthalmic surgery
• Neurological surgery
• Other surgical applications

Market, By End Use

• Hospitals
• Specialty clinics
• Ambulatory surgical centres
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE